Table 2.

Prevalence of anosmia and outcome (in terms of death or discharge) in patients who received tocilizumab (total 53 patients received tocilizumab among them only 5 had anosmia out of them 4 discharged and 1 died). This table again proves that anosmia is related with good outcome. p value-0.174 is not significant due to small size of sample

Outcome	Anosmia present		Anosmia absent
	Number	%	Number	%
Discharge	4	80	18	37.5
Death	1	20	30	62.5
Total	5	100	48	100

CHI square test p value = 0.174 non significant